Anti-inflammatory effects of α7-nicotinic ACh receptors are exerted through interactions with adenylyl cyclase-6.
Simeng ZhuShiqian HuangGuofang XiaJin WuYan ShenYing WangRennolds S OstromAilian DuChengxing ShenCongfeng XuPublished in: British journal of pharmacology (2021)
The α7-nAChRs inhibit inflammation through activating adenylyl cyclase-6 and promoting degradation of TLR4. The use of α7-nAChR agonists may represent a novel therapeutic approach for treating COPD and possibly other inflammatory diseases.